Coppell Advisory Solutions »

Oncternal Therapeutics shares owned by Coppell Advisory Solutions

Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Coppell Advisory Solutions from 13F filings

Historical chart of Coppell Advisory Solutions investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Coppell Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Coppell Advisory Solutions

Quarter filed Position value Share count Share price at filing
2023-12-31 $11 20 0.55
2023-09-30 $58 58 1.00
2023-06-30 $12 36 0.36
2022-12-31 $58 58 1.00

More positions owned by Coppell Advisory Solutions

First Tr Exchange Traded Fd Iv First Tr Enh New Etf FTSM (FTSM)
First Tr Exchange Traded Fd Vi Tcw Opportunis Etf Fixd (FIXD)
Microsoft Corp MSFT (MSFT)
Apple Aapl (AAPL)
Jp Morgan Chase & Co JPM (JPM)
Kingsmen Resources Ord KNG (KNG)
Spdr Series Trust Spdr Bloomberg Etf Bil (BIL)
Broadcom Avgo (AVGO)
Ishares Trust Short Treas Bd Etf SHV (SHV)
First Trust Large Cap Value Al Com Shs Etf Fta (FTA)
Ishares Trust Core S&p500 Etf Ivv (IVV)
First Trust Exchange-traded Fu Cap Strength Etf FTCS (FTCS)
Vaneck Vectors Etf Trust Invt Grade Fltg Etf FLTR (FLTR)
Vanguard S&p 500 Etf Voo (VOO)
First Tst Value Li Shs Etf FVD (FVD)

View all positions for Coppell Advisory Solutions

Top funds holding Oncternal Therapeutics

Millennium Management
Two Sigma Advisers
Two Sigma Investments
Axxcess Wealth Management
Two Sigma Securities
Citadel Advisors
Beta Wealth
IPG Investment Advisors
Steward Partners Investment Advisory
Bank of America Corporation
Coppell Advisory Solutions
Delta Asset Management

View all funds holding Oncternal Therapeutics